Cooper Companies | COO - Capital Y Las Reservas





Capital Y Las Reservas Cambio Fecha
Abbott USD 52.06B 69M 2026-03
Align Technology USD 4.15B 100.27M 2026-03
AtriCure USD 516.43M 24.74M 2026-06
Avanos Medical USD 782.1M 3.9M 2026-03
Bausch Health Companies USD -2.06B 1.5B 2026-03
Baxter International USD 6.04B 86M 2026-03
Bayer EUR 28.85B 2.9B 2026-03
Becton, Dickinson and Co. USD 24.13B 1.15B 2026-03
Boston Scientific USD 25.86B 1.63B 2026-03
Cooper Companies USD 8.36B 124.7M 2025-12
Dentsply International USD 1.32B 21M 2026-03
Dexcom USD 2.96B 210.9M 2026-03
Edwards Lifesciences USD 10.33B 10.1M 2026-03
Globus Medical USD 4.73B 159.06M 2026-03
Haemonetics USD 796.32M 115.13M 2026-03
Inogen USD 197.18M 2.32M 2025-09
Insulet USD 1.3B 212.6M 2026-03
Integra LifeSciences USD 1.04B 1.06M 2026-03
Intuitive Surgical USD 18.17B 693.9M 2026-06
J&J USD 84.97B 3.78B 2026-06
Medtronic USD 48.99B 128M 2025-12
Merit Medical Systems USD 1.63B 42.42M 2026-03
Novartis USD 38.93B 7.2B 2026-03
ResMed USD 6.49B 171.03M 2026-03
STAAR Surgical USD 352.37M 8.18M 2026-03
Steris USD 7.18B 29.1M 2026-03
Stryker USD 22.42B 635M 2025-12
Tandem Diabetes Care USD 132.4M 22.77M 2026-03
Teleflex USD 3.08B 40.33M 2026-03
Utah Medical Products USD 119.27M 1.02M 2025-12
Zimmer Biomet Holdings USD 12.68B 16.1M 2026-03